TipRanks
Neurobiological Technologies Inc (NTII)
OTHER OTC:NTII
US Market

Neurobiological Technologies (NTII) Income Statement

1 Followers

Neurobiological Technologies Income Statement

Last quarter (Q0 0), Neurobiological Technologies's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Neurobiological Technologies's net income was $5.41M. See Neurobiological Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 09Jun 08Jun 07Jun 06Jun 05
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 26.35M$ 14.76M$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ 3.25M$ -16.49M$ -15.37M$ -16.24M$ -12.48M
Operating Income
$ 3.68M$ -16.70M$ -15.60M$ -16.44M$ -12.58M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 3.12M$ -16.32M$ -14.13M$ -27.84M$ -24.98M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
― ― ― ― ―
Weighted Average Shares Outstanding (Diluted)
― ― ― ― ―

Neurobiological Technologies Earnings and Revenue History